TD Ameritrade Investment Management’s Fresenius Medical Care FMS Stock Holding History

TD Ameritrade Investment Management’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-154	Closed	-$4K	–	608
2022 Q2	$4K	Hold	154	–	–	﹤0.01%	485
2022 Q1	$5K	Hold	154	–	–	﹤0.01%	547
2021 Q4	$5K	Buy	154 +50	+48%	+$1.65K	﹤0.01%	531
2021 Q3	$4K	Buy	104 +12	+13%	+$469	﹤0.01%	531
2021 Q2	$4K	Sell	92 -12	-12%	-$480	﹤0.01%	543
2021 Q1	$4K	Hold	104	–	–	﹤0.01%	536
2020 Q4	$4K	Hold	104	–	–	﹤0.01%	536
2020 Q3	$4K	Hold	104	–	–	﹤0.01%	531
2020 Q2	$5K	Sell	104 -4	-4%	-$158	﹤0.01%	509
2020 Q1	$4K	Buy	+108	New	+$4.01K	﹤0.01%	497

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TD Ameritrade Investment Management's FMS Position: Q3 2022 in Review

TD Ameritrade Investment Management sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 154 shares — an estimated $4K sold.

TD Ameritrade Investment Management first reported a position in FMS in Q1 2020 and held it in 10 quarters. The position peaked at $5K in Q1 2022. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

TD Ameritrade Investment Management reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
TD Ameritrade Investment Management sold 154 Fresenius Medical Care shares in Q3 2022, an estimated $4K.
TD Ameritrade Investment Management first reported a position in Fresenius Medical Care in Q1 2020 and held it in 10 quarters.
TD Ameritrade Investment Management's Fresenius Medical Care position peaked at $5K in Q1 2022.
141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.